SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 28, 16:15
839.55
-2.4 (-0.29%)
VOLUME 147,374
LIVE
NSE
Nov 28, 16:15
839.70
-2.25 (-0.27%)
VOLUME 2,172,117
News on Sun Pharmaceutical Industries
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy ONGC, Sun Pharma, Aurobindo Pharma: Sudarshan Sukhani 

4.52 pm | 27 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy ONGC, Sun Pharma and Aurobindo Pharma....

Mkt momentum on upside, may surprise going ahead: Sukhani 

3.43 pm | 27 Nov 2014 |  Source: CNBC-TV18

In a discussion on CNBC-TV18, Sudarshan Sukahni of s2analytics, Neeraj Deewan of Quantum Securities and Devang Mehta of Anand Rathi Financial Services...

Sun Pharma may test Rs 880: Yogesh Mehta 

1.47 pm | 27 Nov 2014 |  Source: CNBC-TV18

Yogesh Mehta of Motilal Oswal Securities is of the view that Sun Pharmaceutical Industries may test Rs 880....

Buy Ambuja Cements, Sun Pharma, Mindtree: Sudarshan Sukhani 

3.22 pm | 26 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Ambuja Cements, Sun Pharma and Mindtree....

Angel Broking neutral on Sun Pharmaceutical Industries

2.33 pm | 26 Nov 2014 |  Source: Moneycontrol.com

Angel Broking has maintained a neutral rating on Sun Pharmaceutical Industries, in its November 14, 2014 research report....

Prefer Sun Pharmaceutical Industries: Sanjay Dutt 

11.05 am | 25 Nov 2014 |  Source: CNBC-TV18

Sanjay Dutt, Director at Quantum Securities is of the view that one may prefer Sun Pharmaceutical Industries....

Hold Sun Pharma; target of Rs 915: KRChoksey

10.07 am | 25 Nov 2014 |  Source: Moneycontrol.com

Brokerage house KRChoksey has recommended a hold rating on Sun Pharmaceutical Industries with a target price of Rs 915 per share in its November 14, 2...

Sun Pharmaceutical: Updates on scheme of arrangement

2.15 pm | 24 Nov 2014 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has ...

Here are Parag Thakkar's few trading ideas 

9.47 am | 24 Nov 2014 |  Source: CNBC-TV18

Watch the interview of Parag Thakkar of HDFC Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook ...

CCI begins public scrutiny of Holcim-Lafarge deal

2.25 pm | 22 Nov 2014 |  Source: PTI

The comments with respect to the Holcim-Lafarge deal need to be submitted to the CCI (Competition Commission of India) within 15 days, along with supp...

Be careful while betting on midcaps; like Kotak: Dimensions 

10.00 am | 21 Nov 2014 |  Source: CNBC-TV18

Ajay Srivastava is bullish on cement, tyre, IT and pharma space. Among stocks, Srivastava likes JK Lakshmi, Shree cement, Sun Pharma, Lupin, Tech Mahi...

Sun Pharma consolidated Sep '14 sales at Rs 4,769.49 crore

3.27 pm | 20 Nov 2014 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries has reported a consolidated total income from operations of Rs 4,769.49 crore and a net profit of Rs 1,572.46 crore for ...

Sun Pharma, Lupin, Dr Reddy's preferred picks: Agarwal 

2.29 pm | 20 Nov 2014 |  Source: CNBC-TV18

According to Nitin Agrawal - Pharma Analyst at IDFC Securities, Sun Pharma, Lupin and Dr Reddy's labs are the preferred picks....

Here's why Sun, Lupin, DRL are still best pharma bets 

1.04 pm | 20 Nov 2014 |  Source: CNBC-TV18

Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the...

Ranbaxy to exit Nifty Junior index from November 28

7.34 pm | 18 Nov 2014 |  Source: PTI

These changes would be effective from November 28, 2014. Ranbaxy has been already dropped from NSE's benchmark index, Nifty....

Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte

2.55 pm | 18 Nov 2014 |  Source: Reuters

In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency'...

Krish Subramanium recommends bull spread in Sun Pharma 

2.33 pm | 18 Nov 2014 |  Source: CNBC-TV18

Krish Subramanium of Asit C. Mehta Investment Interrmediates recommends bull spread in Sun Pharma wherein one can buy 880 Call and sell 920 Call....

Here are Krish Subramanyam's few trading ideas 

12.19 pm | 18 Nov 2014 |  Source: CNBC-TV18

Watch the interview of Krish Subramanyam, Asit C. Mehta Investment Interrmediates with Latha Venkatesh & Anuj Singhal on CNBC-TV18, in which he shared...

Sun, Merck to dissolve branded generics JV? 

7.17 pm | 14 Nov 2014 |  Source: CNBC-TV18

Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting...

Merger with Ranbaxy might get delayed: Sun CFO Baldota 

11.59 am | 14 Nov 2014 |  Source: CNBC-TV18

The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally....

1 2 3 4 5 6 7
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.